134 related articles for article (PubMed ID: 35864050)
1. A national evaluation of the predictors of compliance and survival from adjuvant chemotherapy in high-risk stage II colon cancer: A National Cancer Database (NCDB) analysis.
Reif de Paula T; Gorroochurn P; Haas EM; Keller DS
Surgery; 2022 Sep; 172(3):859-868. PubMed ID: 35864050
[TBL] [Abstract][Full Text] [Related]
2. A national evaluation of adjuvant chemotherapy in pT4N0M0 colon cancer from the National Cancer Database.
Reif de Paula T; Keller DS
J Natl Cancer Inst; 2023 Dec; 115(12):1616-1625. PubMed ID: 37584736
[TBL] [Abstract][Full Text] [Related]
3. A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database.
Reif de Paula T; Gorroochurn P; Simon HL; Haas EM; Keller DS
Colorectal Dis; 2022 Jan; 24(1):40-49. PubMed ID: 34605166
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer.
Casadaban L; Rauscher G; Aklilu M; Villenes D; Freels S; Maker AV
Cancer; 2016 Nov; 122(21):3277-3287. PubMed ID: 27417445
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemotherapy does not provide survival benefits to elderly patients with stage II colon cancer.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Sci Rep; 2019 Aug; 9(1):11846. PubMed ID: 31413354
[TBL] [Abstract][Full Text] [Related]
6. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
7. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
[No Abstract] [Full Text] [Related]
8. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
9. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
[TBL] [Abstract][Full Text] [Related]
10. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer.
McKenzie S; Nelson R; Mailey B; Lee W; Chung V; Shibata S; Garcia-Aguilar J; Kim J
Cancer; 2011 Dec; 117(24):5493-9. PubMed ID: 21692068
[TBL] [Abstract][Full Text] [Related]
12. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
[TBL] [Abstract][Full Text] [Related]
13. N1c colon cancer and the use of adjuvant chemotherapy: a current audit of the National Cancer Database.
Simon HL; Reif de Paula T; Spigel ZA; Keller DS
Colorectal Dis; 2021 Mar; 23(3):653-663. PubMed ID: 33064353
[TBL] [Abstract][Full Text] [Related]
14. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy is associated with improved overall survival in select patients with Stage II colon cancer: A National Cancer Database analysis.
Grant RRC; Khan TM; Gregory SN; Coakley BA; Hernandez JM; Davis JL; Blakely AM
J Surg Oncol; 2022 Sep; 126(4):748-756. PubMed ID: 35698854
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.
O'Connor ES; Greenblatt DY; LoConte NK; Gangnon RE; Liou JI; Heise CP; Smith MA
J Clin Oncol; 2011 Sep; 29(25):3381-8. PubMed ID: 21788561
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy use and outcomes of patients with high-risk versus low-risk stage II colon cancer.
Kumar A; Kennecke HF; Renouf DJ; Lim HJ; Gill S; Woods R; Speers C; Cheung WY
Cancer; 2015 Feb; 121(4):527-34. PubMed ID: 25332117
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
[TBL] [Abstract][Full Text] [Related]
20. Oncologic outcomes after adjuvant chemotherapy with capecitabine compared to 5-fluorouracil/leucovorin for geriatric stage II colon cancer: a retrospective cohort study.
Lee KY; Park JW; Lee KY; Cho S; Kwon YH; Kim MJ; Ryoo SB; Jeong SY; Park KJ
Int J Colorectal Dis; 2019 Apr; 34(4):629-639. PubMed ID: 30661101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
